2021 #SurvivingSepsis Guidelines Website:sccm.org/SurvivingSepsi… Link Article: journals.lww.com/ccmjournal/Cit… 👊 Best practices & recommendations for treatment of #sepsis #septic #AdultICU

#pharmICU #TwitteRx what are you doing to address sleep in your ICU’s? Let’s spread some awareness and strategies! Chris Carter, PharmD, BCCCP, FCCM Critical Care Pharmacists John Devlin, PharmD, BCCCP, FCCP, MCCM Mojdeh Heavner Caitlin S. Brown Eljim Julie Willmon Christina Rose Pam Ting Ting Wu

Ting Ting Wu and Mark vd Boogaard -thx for ur help with this rigorous MV analysis. But the neuro effects of ketamine are complex and many time-dependent risk factors for ICU delirium exist. A large, prospective ICU ketamine analgosedation RCT is much needed to confirm our results.

😵‍💫#Delirium in #ICU something missing? Individual symptoms likely to remain unnoticed/unaddressed: how to routinely assess? Patients suffer from fear, paranoia, anxiety: delivery of safe/effective care challenging. 🖇️rdcu.be/cKayW 🖇️Refers to rdcu.be/cKayD

The #ADS22Indy preconference starts in less than 2 hours! Attendees learn & connect with experts on #delirium & healthy aging - Drs. Terry Fulmer & Alice Bonner, John Devlin, PharmD, BCCCP, FCCP, MCCM Sharon Inouye, MD Christine Waszynski Jim Rudolph Donna Fick, PhD, GCNS-BC, FAAN among many others!!

Thanks to NIDUS Delirium Network and #ADS2022Indy for the opportunity to present my research. Baseline anxiety+depression is an important risk factor for ICU delirium-lots of additional research to conduct. thx to John Devlin, PharmD, BCCCP, FCCP, MCCM Mark vd Boogaard Joe Bienvenu for their mentorship

Our analysis suggests ICU clinicians should consider whether anxiety +/- depression (or a history of either) is present when characterizing risk factors for delirium in their patients. Ting Ting Wu and I appreciate the collaboration with Mark vd Boogaard and Joe Bienvenu #bouve

Crit care pharm perceptions and practices re: cont. neuro blockers for severe ARDS generally meet best evidence/guideline reccs; important differences exist for COVID+ patients and with MD perceptions/ practices. Karen E. A. Burns @accpritprn Annals of Pharmacotherapy Journal doi.org/10.1177/106002…

Learning the importance of re-discovering our humanity during A SOLD OUT evening with WesElyMD at the American Delirium Society while listening to excerpts from his book Every Deep Drawn Breath that included inspiring patient stories.

Building upon the foundation laid by 〽️atthew Duprey and benefiting from the valuable mentorship of both John Devlin, PharmD, BCCCP, FCCP, MCCM and 〽️atthew Duprey , I shared our research findings on pain-delirium under NIDUS Delirium Network oral presentation section. Thank you American Delirium Society for a wonderful meeting!

Thank you NIDUS Delirium Network and John Devlin, PharmD, BCCCP, FCCP, MCCM 〽️atthew Duprey for the amazing mentorship

Expressing my appreciation to my mentors John Devlin, PharmD, BCCCP, FCCP, MCCM and Louisa Smith for the collaboration. Addressing missingness in cohort studies is crucial for robust ICU research.

Congrats to S Kane-Gill for delivering a stellar @accp 2023 Therapeutics Frontier lecture on how we can help identify and prevent medication-related kidney disease Judith Jacobi Greg Martin John Kellum ACCP CRIT PRN SCCM Clinical Pharmacy and Pharmacology Section

Congratulations to Sam on completing his PhD in pharmacoepi!

For ICU pts with agitated delirium, should clonidine or antipsychotics be used? In this JCriticalCare paper Ting Ting Wu Louisa Smith + I found clonidine (vs APs) is associated with a 83% greater daily likelihood of delirium resolution. RCTs are needed! bit.ly/3uq4kAl

Does ICU pain increase the daily risk for transitioning to delirium? In a rigorous Markov analysis, Ting Ting Wu 〽️atthew Duprey, Irene Zaal, Celine Gelinas, Arjen Slooter and I suggest it may not (aOR 0.96; 95% CI, 0.76–1.21) WesElyMD Dale Needham, MD, PhD bit.ly/3uPd1Ez

Always an important & intriguing clinical question but hard to answer…

1. Relationship between pain and delirium pubmed.ncbi.nlm.nih.gov/38053750/ Ting Ting Wu 〽️atthew Duprey John Devlin, PharmD, BCCCP, FCCP, MCCM 2. Comparison of 1st v. 2nd-line agents for SBP prophylaxis pubmed.ncbi.nlm.nih.gov/36680798/ 3. Impact on DKA resolution with 2-bag fluid order set pubmed.ncbi.nlm.nih.gov/37021360/

Application of #CausalInference methods in individual-participant data meta-analyses in medicine: Addressing data handling and reporting gaps with new proposed reporting guidelines doi.org/10.1186/s12874… Richard Riley (R²) #IPDMA #MetaAnalysis #IPD

🧵 New Special Communication examines drawing causal inferences about the effects of interventions from observational studies in medical journals and suggests a framework that might be used. ja.ma/3UxeAjL